Beyond Air, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Beyond Air, Inc. (XAIR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.04M, a 34.31% decline year-over-year.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $1.50M, a 39.40% decline year-over-year.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.77M, a 43.27% decline year-over-year.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.58M, a 53.33% decline year-over-year.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $5.28M, a 42.25% decline from fiscal 2025.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $9.15M, a 57.14% decline from fiscal 2024.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $21.34M, a 9.09% increase from fiscal 2023.
- Beyond Air, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $19.56M, a 149.76% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.04M 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | $5.28M 10-K · filed 2026-06-26 | |||||
| 2025-12-31 | $1.50M 10-Q · filed 2026-02-13 | $3.28M derived: sum of 2 quarters · filed 2026-02-13 | $4.86M derived: sum of 3 quarters · filed 2026-08-13 | |||
| 2025-09-30 | $1.77M 10-Q · filed 2026-02-13 | $3.35M derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.58M 10-Q · filed 2026-08-13 | |||||
| 2025-03-31 | $9.15M 10-K · filed 2026-06-26 | |||||
| 2024-12-31 | $2.48M 10-Q · filed 2026-02-13 | $5.61M derived: sum of 2 quarters · filed 2026-02-13 | $8.99M derived: sum of 3 quarters · filed 2026-02-13 | |||
| 2024-09-30 | $3.13M 10-Q · filed 2026-02-13 | $6.51M derived: sum of 2 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $3.38M 10-Q · filed 2026-02-13 | |||||
| 2024-03-31 | $21.34M 10-K · filed 2025-06-20 | |||||
| 2023-12-31 | $6.43M 10-Q · filed 2025-02-10 | $12.89M derived: sum of 2 quarters · filed 2025-02-10 | $19.01M derived: sum of 3 quarters · filed 2025-02-10 | |||
| 2023-09-30 | $6.46M 10-Q · filed 2025-02-10 | $12.57M derived: sum of 2 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $6.12M 10-Q · filed 2025-02-10 | |||||
| 2023-03-31 | $19.56M 10-K · filed 2024-06-24 | |||||
| 2022-12-31 | $5.87M 10-Q · filed 2024-02-12 | $10.58M derived: sum of 2 quarters · filed 2024-02-12 | $15.20M derived: sum of 3 quarters · filed 2024-02-12 | |||
| 2022-09-30 | $4.71M 10-Q · filed 2024-02-12 | $9.34M derived: sum of 2 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $4.62M 10-Q · filed 2024-02-12 | |||||
| 2022-03-31 | $7.83M 10-K · filed 2023-06-22 | |||||
| 2021-12-31 | $2.12M 10-Q · filed 2023-02-10 | $3.27M derived: sum of 2 quarters · filed 2023-02-10 | $4.49M derived: sum of 3 quarters · filed 2023-02-10 | |||
| 2021-09-30 | $1.16M 10-Q · filed 2023-02-10 | $2.37M derived: sum of 2 quarters · filed 2023-02-10 | ||||
| 2021-06-30 | $1.22M 10-Q · filed 2023-02-10 | $1.22M 10-Q · filed 2021-08-10 | ||||
| 2021-03-31 | $4.89M 10-K · filed 2022-06-29 | $4.89M 10-K · filed 2021-06-10 | ||||
| 2020-12-31 | $1.06M 10-Q · filed 2022-02-10 | $1.06M 10-Q · filed 2021-02-09 | $2.24M derived: sum of 2 quarters · filed 2022-02-10 | $4.05M derived: sum of 3 quarters · filed 2022-02-10 | ||
| 2020-09-30 | $1.18M 10-Q · filed 2022-02-10 | $1.18M 10-Q · filed 2020-11-12 | $2.99M derived: sum of 2 quarters · filed 2022-02-10 | |||
| 2020-06-30 | $1.81M 10-Q · filed 2022-02-10 | $1.81M 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | $3.48M 10-K · filed 2021-06-10 | $3.48M 10-K · filed 2020-06-23 | ||||
| 2019-12-31 | $714.57K 10-Q · filed 2021-02-09 | $1.64M derived: sum of 2 quarters · filed 2021-02-09 | $2.56M derived: sum of 3 quarters · filed 2021-02-09 | |||
| 2019-09-30 | $923.00K 10-Q · filed 2021-02-09 | $1.84M derived: sum of 2 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $919.04K 10-Q · filed 2021-02-09 | |||||
| 2019-03-31 | $2.55M 10-K · filed 2020-06-23 | |||||
| 2018-12-31 | $771.89K 10-Q · filed 2020-02-07 | $1.61M derived: sum of 2 quarters · filed 2020-02-07 | $1.69M derived: sum of 3 quarters · filed 2020-02-07 | |||
| 2018-09-30 | $842.01K 10-Q · filed 2020-02-07 | $922.01K derived: sum of 2 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $80.00K 10-Q · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |